Infections Caused by Fusarium Species in Pediatric Cancer Patients and Review of Published Literature

  • Mariana Volpe Arnoni
  • Claudete Rodrigues Paula
  • Marcos Ereno Auler
  • Cirilo Cesar Naozuka Simões
  • Shirley Nakano
  • Maria Walderez Szeszs
  • Márcia de Souza Carvalho Melhem
  • Virgínia Bodelão Richini Pereira
  • Hans Garcia Garces
  • Eduardo Bagagli
  • Eriques Gonçalves Silva
  • Melissa Ferreira de Macêdo
  • Luciana da Silva Ruiz
Short Communication
  • 62 Downloads

Abstract

Fusarium species have emerged as responsible for a broad spectrum of infections, including superficial, locally invasive and disseminated ones, especially in the hospital environment. Since there are few reports of invasive and disseminated fusariosis in children, the aim of this study was to report four cases of nosocomial infection caused by this microorganism in children with cancer hospitalized in a public children’s hospital located in Brazil. Two of these patients were female and two were male. All patients presented febrile neutropenia, while three patients had acute lymphocytic leukemia and one patient had Wilms’ tumor as underlying disease. In two cases, fungi were isolated from blood and identified as Fusarium oxysporum species complex after phenotypic and genotypic studies, while in two other cases fungi were isolated from skin biopsies and identified as Fusarium solani species complex. One patient died 12 days after the onset of cutaneous lesions. All isolates, after susceptibility testing, presented high levels of minimum inhibitory concentration for itraconazole, voriconazole and amphotericin B. Considering the emergence of filamentous fungi as etiologic agents of nosocomial infections, health professionals should be aware of the problems these infections, especially fungal ones, may cause to debilitated patients.

Keywords

Fusarium spp. Children Cancer Nosocomial infection 

Notes

Acknowledgements

We would like to thank “Fundação de Amparo à Pesquisa do Estado de São Paulo” (Fapesp - 2014/16507-0) for financial support and Letícia Campos for English review.

References

  1. 1.
    Tragiannidis A, Dokos Ch, Sidi V, Papageorgiou T, Koliouskas D, Karamouzis M, et al. Alterations of bone mineral metabolism of children with different cell lineage types of acute lymphoblastic leukaemia under chemotherapy. Hippokratia. 2011;15:43–7.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Georgiadou SP, Pongas G, Fitzgerald NE, Lewis RE, Rytting M, Marom EM, et al. Invasive mold infections in pediatric cancer patients reflect heterogeneity in etiology, presentation, and outcome: a 10-year, single-institution, retrospective study. J Pediatr Infect Dis Soc. 2012;1:125–35.CrossRefGoogle Scholar
  3. 3.
    Nucci M, Anaissie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007;20:695–704.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Guarro J. Fusarium, a complex infection caused by a high diversity of fungal species refractory to treatment. Eur J Clin Microbiol Infect Dis. 2013;32:1491–500.CrossRefPubMedGoogle Scholar
  5. 5.
    Muhammed M, Anagnostou T, Desalermos A, Kourkoumpetis TK, Carneiro HA, Glavis-Bloom J, et al. Fusarium infection: report of 26 cases and review of 97 cases from the literature. Medicine. 2013;92:305–16.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Tortorano AM, Prigitano A, Esposto MC, Arsic Arsenijevic V, Kolarovic J, Ivanovic D, et al. ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp and others. Clin Microbiol Infect. 2014;20(Supp 3):27–46.CrossRefPubMedGoogle Scholar
  7. 7.
    Boutati EI, Anaissie J. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years’ experience at a cancer center and implications for management. Blood. 1997;90:999–1008.PubMedGoogle Scholar
  8. 8.
    Nucci M, Anaissie J. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis J. 2002;35:909–20.CrossRefGoogle Scholar
  9. 9.
    van Diepeningen AD, Brankovics B, Iltes J, van der Lee TA, Waalwijk C. Diagnosis of Fusarium infections: approaches to identification by the clinical mycology laboratory. Curr Fungal Infect Rep. 2015;9(3):135–43.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Nucci M, Anaissie EJ, Queiroz-Telles F, Martins CA, Trabasso P, Solza C, et al. Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection. Cancer. 2003;98:315–9.CrossRefPubMedGoogle Scholar
  11. 11.
    White TJ, Bruns T, Lee S, Taylor J. Amplification and direct sequencing of fungal ribosomal RNA for phylogenetics. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. San Diego: Academic Press; 1990. p. 315–21.Google Scholar
  12. 12.
    O’Donnell K, Sutton DA, Rinaldi MG, Sarver BA, Balajee SA, Schroers HJ, et al. Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol. 2010;48:3708–18.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Kumar S, Stecher G, Tamura K. MEGA7: molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol. 2016;33(7):1870–4.  https://doi.org/10.1093/molbev/msw054.CrossRefPubMedGoogle Scholar
  14. 14.
    Clinical and Laboratory Standarts Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved standard, 2nd ed. CLSI document M38-A2. 2008. Clinical and Laboratory Standarts Institute, Villanova, PA; 2008.Google Scholar
  15. 15.
    Okada H, Hamatani S, Kondo M, Imai T, Itoh S, Isobe K, et al. Successful treatment of disseminated Fusarium infection in an infant with leukemia. Int J Hematol. 2000;72(4):494–8.PubMedGoogle Scholar
  16. 16.
    Chi CC, Wang SH. Disseminated cutaneous Fusarium moniliforme infections in a leukemic child. Int J Dermatol. 2007;46(5):487–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Marcoux D, Jafarian F, Joncas V, Buteau C, Kokta V, Moghrabi A. Deep cutaneous fungal infections in immunocompromised children. J Am Acad Dermatol. 2009;61(5):857–64.CrossRefPubMedGoogle Scholar
  18. 18.
    Gurusidappa SB, Mamatha HS. Fusarial skin lesion in immunocompromised. Indian J Cancer. 2011;48(1):116–7.CrossRefPubMedGoogle Scholar
  19. 19.
    Morris SK, Allen UD, Gupta S, Richardson SE. Breakthrough filamentous fungal infections in pediatric hematopoetic stem cell transplant and oncology patients receiving caspofungin. Can J Infect Dis Med Microbiol. 2012;23:179–82.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Morel LN, Cid PM, De Celada RM, Rodríguez MF, Beato M, Arias ÁG, et al. Disseminated fusariosis in a pediatric population. Pediatr Dermatol. 2013;30(6):e255–6.CrossRefPubMedGoogle Scholar
  21. 21.
    Litvinov N, da Silva MT, van der Heijden IM, Graça MG, Marques de Oliveira L, Fu L, et al. An outbreak of invasive fusarium in a children’s cancer hospital. Clin Microbiol Infect. 2015;21:1–7.CrossRefGoogle Scholar
  22. 22.
    Schwartz KL, Sheffield H, Richardson SE, Sung L, Morris SK. Invasive Fusarium: a single pediatric center 15-year experience. J Pediatr Infect Dis Soc. 2015;4:163–70.CrossRefGoogle Scholar
  23. 23.
    Bhattacharyya A, Chandy M, Roy MK, Goel G, Hmar L, Bhattacharya S, et al. Infection control challenges of infrequent and rare fungal pathogens: lessons from disseminated Fusarium and Kodamaea ohmeri infections. Infect Control Hosp Epidemiol. 2015;36(7):866–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Rosanova MT, Brizuela M, Villasboas M, Guarracino F, Alvarez V, Santos P, et al. Fusarium spp infections in a pediatric burn unit: nine years of experience. Braz J Infect Dis. 2016;20(4):389–92.CrossRefPubMedGoogle Scholar
  25. 25.
    Hassler A, Lieb A, Seidel D, Cesaro S, Greil J, Klimko N, et al. Disseminated fusariosis in immunocompromised children-analysis of recent cases identified in the global fungiscope registry. Pediatr Infect Dis J. 2017;36(2):230–1.CrossRefPubMedGoogle Scholar
  26. 26.
    Álves F, Figueras C. Representación del Grupo de Trabajo de Infecciones Fúngicas de la Sociedad Española de Infectología Pediátrica. Infecciones Fúngicas Invasivas Emergentes. Anales de Pediatría. 2010;73:52.e1–6.Google Scholar
  27. 27.
    Short DPG, O’Donnell K, Zhang N, et al. Widespread occurrence of diverse pathogenic types of the fungus Fusarium in bathroom plumbing drains. J Clin Microbiol. 2011;49:4264–72.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Sautour M, Edel-Hermann V, Steinberg C, Sixt N, Laurent J, Dalle F, et al. Fusarium species recovered from the water distribution system of a French university hospital. Int J Hyg Environ Health. 2012;215:286–92.CrossRefPubMedGoogle Scholar
  29. 29.
    Campo M, Lewis RE, Kontoyiannis DP. Invasive Fusarium in patients with hematologic malignancies at a cancer center: 1998–2009. J Infect. 2010;60:331–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Torres HA, Raad II, Kontoyiannis DP. Infections caused by Fusarium species. J Chemother. 2003;15(Suppl 2):28–35.CrossRefPubMedGoogle Scholar
  31. 31.
    Bodey GP, Boktour M, Mays S, et al. Skin lesions associated with Fusarium infection. J Am Acad Dermatol. 2002;47(5):659–66.CrossRefPubMedGoogle Scholar
  32. 32.
    Al-Rezqi A, Hawkes M, Doyle J, Richardson SE, Allen U. Invasive mold infections in iatrogenically immunocompromised children: an eight-yr review. Pediatr Transplant. 2009;13:545–52.CrossRefPubMedGoogle Scholar
  33. 33.
    Short DP, O’Donnell K, Thrane U, Nielsen KF, Zhang N, Juba JH, Geiser DM. Phylogenetic relationships among members of the Fusarium solani species complex in human infections and the descriptions of F. keratoplasticum sp. nov. and F. petroliphilum stat. nov. Fungal Genet Biol. 2013;53:59–70.CrossRefPubMedGoogle Scholar
  34. 34.
    Muraosa Y, Oguchi M, Yahiro M, Watanabe A, Yaguchi T, Kamei K. Epidemiological Study of Fusarium Species Causing Invasive and Superficial Fusariosis in Japan. Med Mycol J. 2017;58(1):E5–13.CrossRefPubMedGoogle Scholar
  35. 35.
    Jossi M, Ambrosioni J, Macedo-Vinas M, Garbino J. Invasive Fusarium with prolonged fungemia in a patient with acute lymphoblastic leukemia: case report and review of the literature. Int J Infect Dis. 2010;14:354–6.CrossRefGoogle Scholar
  36. 36.
    Van Diepeningen AD, de Hoog GS. Challenges in Fusarium, a Trans-Kingdom Pathogen. Mycopathologia. 2016;181(3–4):161–3.CrossRefPubMedGoogle Scholar
  37. 37.
    Espinel-Ingroff A, Colombo AL, Cordoba S, Dufresne PJ, Fuller J, Ghannoum M, et al. International evaluation of MIC distributions and epidemiological cutoff value (ECV) definitions for Fusarium species identified by molecular methods for the CLSI broth microdilution method. Antimicrob Agents Chemother. 2015;60:1079–84.CrossRefPubMedGoogle Scholar
  38. 38.
    Ruíz-Cendoya M, Mariné M, Rodríguez MM, Guarro J. Interactions between triazoles and amphotericin B in treatment of disseminated murine infection by Fusarium oxysporum. Antimicrob Agents Chemother. 2009;53(4):1705–8.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Lewis R, Hogan H, Howell A, Safdar A. Progressive fusariosis: unpredictable posaconazole bioavailability, and feasibility of recombinant interferon-gamma plus granulocyte macrophage-colony stimulating factor for refractory disseminated infection. Leuk Lymphoma. 2008;49(1):163–5.CrossRefPubMedGoogle Scholar
  40. 40.
    Arikan S, Lozano-Chiu M, Paetznick V, Rex JH. In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp. Antimicrob Agents Chemother. 2002;46(1):245–7.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Rothe A, Seibold M, Hoppe T, Seifert H, Engert A, Caspar C, et al. Combination therapy of disseminated Fusarium oxysporum infection with terbinafine and amphotericin B. Ann Hematol. 2004;83(6):394–7.CrossRefPubMedGoogle Scholar
  42. 42.
    Heyn K, Tredup A, Salvenmoser S, Müller FM. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani. Antimicrob Agents Chemother. 2005;49(12):5157–9.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Groll AH, Castagnola E, Cesaro S, Dalle JH, Engelhard D, Hope W, et al. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol. 2014;15(8):327–40.CrossRefGoogle Scholar
  44. 44.
    Perfect JR, Marr KA, Walsh TJ, Greenberg RN, DuPont B, de la Torre-Cisneros J, et al. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin Infect Dis. 2003;36:1122–3.CrossRefPubMedGoogle Scholar
  45. 45.
    Nucci M, Marr KA, Vehreschild MJ, de Souza CA, Velasco E, Cappellano P, et al. Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect. 2014;20(6):580–5.CrossRefPubMedGoogle Scholar
  46. 46.
    Eiden C, Palenzuela G, Hillaire-Buys D, Margueritte G, Cociglio M, Hansel-Esteller S, et al. Posaconazole-increased vincristine neurotoxicity in a child: a case report. J Pediatr Hematol Oncol. 2009;31(4):292–5.CrossRefPubMedGoogle Scholar
  47. 47.
    Dalyan Cilo B, Al-Hatmi AM, Seyedmousavi S, Rijs AJ, Verweij PE, Ener B, et al. Emergence of fusarioses in a university hospital in Turkey during a 20-year period. Eur J Clin Microbiol Infect Dis. 2015;34(8):1683–91.CrossRefPubMedGoogle Scholar
  48. 48.
    Balajee SA, Borman AM, Brandt ME, Cano J, Cuenca-Estrella M, Dannaoui E, et al. Sequence-based identification of Aspergillus, Fusarium, and Mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol. 2009;47:877–84.CrossRefPubMedGoogle Scholar
  49. 49.
    O’Donnell K, Sutton DA, Rinaldi MG, Gueidan C, Crous PW, Geiser DM. Novel multilocus sequence typing scheme reveals high genetic diversity of human pathogenic members of the Fusarium incarnatum, F. equiseti and F. chlamydosporum species complexes within the United States. J Clin Microbiol. 2009;47:3851–61.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Healy M, Reece K, Walton D, Huong J, Frye S, Raad II, et al. Use of the DiversiLab System for species and strain differentiation of Fusarium species isolates. J Clin Microbiol. 2005;43:5278–80.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  • Mariana Volpe Arnoni
    • 1
  • Claudete Rodrigues Paula
    • 2
  • Marcos Ereno Auler
    • 3
  • Cirilo Cesar Naozuka Simões
    • 1
  • Shirley Nakano
    • 1
  • Maria Walderez Szeszs
    • 4
  • Márcia de Souza Carvalho Melhem
    • 4
  • Virgínia Bodelão Richini Pereira
    • 5
  • Hans Garcia Garces
    • 6
  • Eduardo Bagagli
    • 6
  • Eriques Gonçalves Silva
    • 2
  • Melissa Ferreira de Macêdo
    • 1
  • Luciana da Silva Ruiz
    • 5
    • 7
  1. 1.Hospital Infantil Darcy VargasSão PauloBrazil
  2. 2.Faculdade de OdontologiaUniversidade de São Paulo (USP)São PauloBrazil
  3. 3.Departamento de FarmáciaUniversidade Estadual do Centro-Oeste do Paraná (UNICENTRO)GuarapuavaBrazil
  4. 4.Secção de MicologiaInstituto Adolfo Lutz (IAL)São PauloBrazil
  5. 5.Núcleo de Ciências BiomédicasInstituto Adolfo Lutz (IAL), CLR IIBauruBrazil
  6. 6.Departamento de Microbiologia e ImunologiaUniversidade Estadual Paulista (UNESP)BotucatuBrazil
  7. 7.Instituto Adolfo Lutz - Rua Rubens ArrudaBauruBrazil

Personalised recommendations